메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국독성학회 Toxicological Research Journal of Toxicology and Public Health Vol.20 No.3
발행연도
2004.9
수록면
78 - 87 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
This study was to investigate single and repeated-dose toxicities of DFA IV, a new
candidate of nutraceutical which has preventive effect on anemia and osteoporosis. In single-dose
oral toxicity study, the test article were administered once by gavage to rats at dose level of 0, 2,000
and 5,000 mg/kg. No dead animal, abnormal sign and abnormal necropsy finding was found in control
and treated groups. Thus the approximate lethal dose of DFA IV was considered to be higher
than 5,000 mg/kg in rats. In four week repeated dose oral toxicity study, the test article was administered
once daily by gavage to rats at dose levels of 0, 500, 1,000 and 2,000 mg/kg. No abnormality
was observed in mortality, clinical findings, body weight changes, food and water consumptions,
opthalmoscopic findings, hematological findings, necropsy findings, organ weights and histopathological
findings. In urinalysis, specific gravity was increased in 2,000 mg/kg groups of male rats. In serum
biochemical analysis, creatine phosphokinase was increased in all treatment groups of male rats.
These increases in urine specific gravity and serum creatine phosphokinase activity were not accompanied
with related signs such as histopathological changes or clinical findings. In conclusion, four
week repeated oral dose of DFA IV to rats did not cause apparent toxicological change at the dose of
500, 1,000 or 2000 mg/kg body weight. Thus it is suggested that no-observed-adverse-effect level
(NOAEL) of DFA IV in rats would be 2,000 mg/kg/day body weight.

목차

ABSTRACT

서론

재료 및 방법

결과

고찰 및 결론

감사의 글

참고문헌

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-513-014287304